ArticleDiscover oncology2025

Identification and characterization of lLF2 as a prognostic biomarker in HER2-positive breast cancer using Mendelian randomization and machine learning.

Xiyun Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.